Corbus board member Dr. Yong Ben adopts 10b5-1 plan for up to 10,607 shares

Corbus Pharmaceuticals Holdings, Inc.

Dr. Yong Ben, a board member, adopted a Rule 10b5-1 trading plan on June 14, 2024.
Plan authorizes sale of up to 10,607 shares of CRBP common stock.
Sales may begin September 12, 2024; plan terminates September 11, 2025.
Plan is intended to satisfy affirmative defense under Rule 10b5-1(c).

item 8.01

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-074032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.